I just saw AVH as a star recently, and after reading its reports, I realized that it kept selling RECELL to Europe and Asia before RECELL got approved by FDA, but I saw the sell in EU and Asia were only around half million, why it is such a small figure, I saw it sold over 1 million in US since RECELL got approved by FDA, but why RECELL is more popular than EU and Asia.
So my question is, if RECELL is really a good product, why its sale in EU and Asia is such bad? Why all people (include the investors and the company) think the US sale will rocket? What is the point?
Why AVH's sale in US is better than Europe and Asia
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.20 |
Change
0.270(6.87%) |
Mkt cap ! $219.7M | |||
| Open | High | Low | Value | Volume |
| $4.07 | $4.20 | $4.07 | $1.395M | 337.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $4.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.20 | 11233 | 5 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |
